Integra LifeSciences appoints Jan De Witte as President and CEO, succeeding Peter Arduini

INTEGRA LIFESCIENCES HOLDINGS CORP

Jan De Witte to join prior to end of 2021; also appointed to board of directors.
De Witte previously CEO of Barco N.V. and held senior roles at GE Healthcare IT.
Compensation: $850k base salary, 110% target bonus, $2M initial RSU grant, severance provisions.
Peter Arduini steps down as planned to become GE Healthcare CEO; no disagreement with Integra.
De Witte brings 30-year healthcare/tech experience; appointment follows comprehensive CEO search.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Jan D. De Witte

Director

IART · INTEGRA LIFESCIENCES HOLDINGS CORP

Filed: October 28, 2021, 7:59 PM ET

the Board of Directors of the Company (the “Board”) also appointed Mr. De Witte as a director of the Board effective in connection with the commencement of his employment

Appointed

Jan D. De Witte

President and Chief Executive Officer

IART · INTEGRA LIFESCIENCES HOLDINGS CORP

Filed: October 28, 2021, 7:59 PM ET

On October 28, 2021, Integra LifeSciences Holdings Corporation (the “Company”) announced the appointment of Jan D. De Witte to serve as its President and Chief Executive Officer.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Jan D. De Witte was appointed as Director at INTEGRA LIFESCIENCES HOLDINGS CORP.

Action: appointed
Role: Director

Exact text from the filing

the Board of Directors of the Company (the “Board”) also appointed Mr. De Witte as a director of the Board effective in connection with the commencement of his employment

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Jan D. De Witte was appointed as President and Chief Executive Officer at INTEGRA LIFESCIENCES HOLDINGS CORP.

Action: appointed
Role: President and Chief Executive Officer

Exact text from the filing

On October 28, 2021, Integra LifeSciences Holdings Corporation (the “Company”) announced the appointment of Jan D. De Witte to serve as its President and Chief Executive Officer.

View on SEC.gov

INTEGRA LIFESCIENCES HOLDINGS CORP filing history →

Source: SEC EDGAR

accession 0000917520-21-000043

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.